Anaemia Medicine

Product Details:

Eltrombopag Tablets are oral thrombopoietin receptor agonists used to treat chronic immune thrombocytopenia, severe aplastic anemia, and thrombocytopenia in hepatitis C. They stimulate platelet production in the bone marrow, reducing bleeding risk and supporting safe, sustained platelet levels in refractory conditions.

 

Product Details:

Eltrombopag Tablets are oral thrombopoietin receptor agonists used to treat chronic immune thrombocytopenia, severe aplastic anemia, and thrombocytopenia in hepatitis C. They stimulate platelet production in the bone marrow, reducing bleeding risk and supporting safe, sustained platelet levels in refractory conditions.

 

Product Details:

Eltrombopag Tablets are oral thrombopoietin receptor agonists used to treat chronic immune thrombocytopenia, severe aplastic anemia, and thrombocytopenia in hepatitis C. They stimulate platelet production in the bone marrow, reducing bleeding risk and supporting safe, sustained platelet levels in refractory conditions.

 

Product Details:

Eltrombopag Tablets are oral thrombopoietin receptor agonists used to treat chronic immune thrombocytopenia, severe aplastic anemia, and thrombocytopenia in hepatitis C. They stimulate platelet production in the bone marrow, reducing bleeding risk and supporting safe, sustained platelet levels in refractory conditions.

 

Product Details:

Eltrombopag Tablets are oral thrombopoietin receptor agonists used to treat chronic immune thrombocytopenia, severe aplastic anemia, and thrombocytopenia in hepatitis C. They stimulate platelet production in the bone marrow, reducing bleeding risk and supporting safe, sustained platelet levels in refractory conditions.

 

Product Details:

Eltrombopag Tablets are oral thrombopoietin receptor agonists used to treat chronic immune thrombocytopenia, severe aplastic anemia, and thrombocytopenia in hepatitis C. They stimulate platelet production in the bone marrow, reducing bleeding risk and supporting safe, sustained platelet levels in refractory conditions.

 

Product Details:

Eltrombopag Tablets are oral thrombopoietin receptor agonists used to treat chronic immune thrombocytopenia, severe aplastic anemia, and thrombocytopenia in hepatitis C. They stimulate platelet production in the bone marrow, reducing bleeding risk and supporting safe, sustained platelet levels in refractory conditions.

 

Product Details:

Eltrombopag Tablets are oral thrombopoietin receptor agonists used to treat chronic immune thrombocytopenia, severe aplastic anemia, and thrombocytopenia in hepatitis C. They stimulate platelet production in the bone marrow, reducing bleeding risk and supporting safe, sustained platelet levels in refractory conditions.

 

Product Details:

Eltrombopag Tablets are oral thrombopoietin receptor agonists used to treat chronic immune thrombocytopenia, severe aplastic anemia, and thrombocytopenia in hepatitis C. They stimulate platelet production in the bone marrow, reducing bleeding risk and supporting safe, sustained platelet levels in refractory conditions.

 

Product Details:

Eltrombopag Tablets are oral thrombopoietin receptor agonists used to treat chronic immune thrombocytopenia, severe aplastic anemia, and thrombocytopenia in hepatitis C. They stimulate platelet production in the bone marrow, reducing bleeding risk and supporting safe, sustained platelet levels in refractory conditions.

 

Product Details:

Eltrombopag Tablets are oral thrombopoietin receptor agonists used to treat chronic immune thrombocytopenia, severe aplastic anemia, and thrombocytopenia in hepatitis C. They stimulate platelet production in the bone marrow, reducing bleeding risk and supporting safe, sustained platelet levels in refractory conditions.

 

Product Details:

Eltrombopag Tablets are oral thrombopoietin receptor agonists used to treat chronic immune thrombocytopenia, severe aplastic anemia, and thrombocytopenia in hepatitis C. They stimulate platelet production in the bone marrow, reducing bleeding risk and supporting safe, sustained platelet levels in refractory conditions.

 

Product Details:

Eltrombopag Tablets are oral thrombopoietin receptor agonists used to treat chronic immune thrombocytopenia, severe aplastic anemia, and thrombocytopenia in hepatitis C. They stimulate platelet production in the bone marrow, reducing bleeding risk and supporting safe, sustained platelet levels in refractory conditions.

 

Product Details:

Eltrombopag Tablets are oral thrombopoietin receptor agonists used to treat chronic immune thrombocytopenia, severe aplastic anemia, and thrombocytopenia in hepatitis C. They stimulate platelet production in the bone marrow, reducing bleeding risk and supporting safe, sustained platelet levels in refractory conditions.

 

Additional Information:

• Production Capacity: NA
• Delivery Time: Immediate
• Packaging Details: Trademark shown are property of their respective owners and we do not lay any claim on them. Parallel trade if any is conducted under WTO¿¿¿s TRIPS agreement to which India is a Signatory. On this page we have made an ¿¿¿Honest Reference¿¿¿ of this product under the Trademark Act of India and applicable rules in the Territory of India. We do not claim ownership of displayed Trade mark.

Product Details:

Deferasirox tablets are oral iron chelators used to treat chronic iron overload from blood transfusions in conditions like thalassemia and sickle cell disease. They reduce excess iron, protecting vital organs from damage, and are crucial for long-term transfusion-dependent patient management.

 

Product Details:

Deferasirox tablets are oral iron chelators used to treat chronic iron overload from blood transfusions in conditions like thalassemia and sickle cell disease. They reduce excess iron, protecting vital organs from damage, and are crucial for long-term transfusion-dependent patient management.

 

Product Details:

Deferasirox tablets are oral iron chelators used to treat chronic iron overload from blood transfusions in conditions like thalassemia and sickle cell disease. They reduce excess iron, protecting vital organs from damage, and are crucial for long-term transfusion-dependent patient management.

 

Product Details:

Deferasirox tablets are oral iron chelators used to treat chronic iron overload from blood transfusions in conditions like thalassemia and sickle cell disease. They reduce excess iron, protecting vital organs from damage, and are crucial for long-term transfusion-dependent patient management.

 

Product Details:

Deferasirox tablets are oral iron chelators used to treat chronic iron overload from blood transfusions in conditions like thalassemia and sickle cell disease. They reduce excess iron, protecting vital organs from damage, and are crucial for long-term transfusion-dependent patient management.

 

Product Details:

Deferasirox tablets are oral iron chelators used to treat chronic iron overload from blood transfusions in conditions like thalassemia and sickle cell disease. They reduce excess iron, protecting vital organs from damage, and are crucial for long-term transfusion-dependent patient management.

 

Product Details:

Deferasirox tablets are oral iron chelators used to treat chronic iron overload from blood transfusions in conditions like thalassemia and sickle cell disease. They reduce excess iron, protecting vital organs from damage, and are crucial for long-term transfusion-dependent patient management.

 

Product Details:

Deferasirox tablets are oral iron chelators used to treat chronic iron overload from blood transfusions in conditions like thalassemia and sickle cell disease. They reduce excess iron, protecting vital organs from damage, and are crucial for long-term transfusion-dependent patient management.

 

Product Details:

Deferasirox tablets are oral iron chelators used to treat chronic iron overload from blood transfusions in conditions like thalassemia and sickle cell disease. They reduce excess iron, protecting vital organs from damage, and are crucial for long-term transfusion-dependent patient management.

 

Product Details:

Deferasirox Medicines called iron chelators are used to remove the excess iron and reduce the risk of it causing organ damage. Deferasirox film-coated tablets is used to treat chronic iron overload caused by frequent blood transfusions in patients with beta thalassaemia major aged 6 years and older